Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.

Emerging data suggest that SSeCKS/Gravin/AKAP12 ("AKAP12"), originally identified as an autoantigen in cases of myasthenia gravis, controls multiple biological processes through its ability to scaffold key signaling proteins such as protein kinase (PK) C and A, calmodulin, cyclins, phosphoinositides, "long" β-1,4 galactosyltransferase (GalTase) isoform, Src, as well as the actin cytoskeleton in a spatiotemporal manner. Specialized functions attributed to AKAP12 include the suppression of cancer malignancy, especially aspects of metastatic progression, regulation of blood-brain and blood-retina barrier formation, and resensitization of β2-adrenergic pain receptors. Recent data identify a direct role for AKAP12 in cytokinesis completion, further suggesting a function as a negative regulator of cell senescence. The current review will discuss the emerging knowledge base of AKAP12-related biological roles and how the factors that affect AKAP12 expression or that interact with AKAP12 at the protein level control cancer progression and blood-tissue barrier formation.

[1]  G. Semenza,et al.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. , 1997, Cancer research.

[2]  Yoon Kyung Choi,et al.  AKAP12 in astrocytes induces barrier functions in human endothelial cells through protein kinase Cζ , 2008, The FEBS journal.

[3]  A. Hyman,et al.  Genome-scale RNAi profiling of cell division in human tissue culture cells , 2007, Nature Cell Biology.

[4]  R. Weinberg,et al.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.

[5]  Leonhard Müllauer,et al.  Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. , 2008, Cancer research.

[6]  Xianqun Fan,et al.  Efficient identification of phosphatidylserine-binding proteins by ORF phage display. , 2009, Biochemical and biophysical research communications.

[7]  H. Koeffler,et al.  Restoration of C/EBPα Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation* , 2003, Journal of Biological Chemistry.

[8]  J. Chen,et al.  A novel retinoid-response gene set in vascular smooth muscle cells. , 2001, Biochemical and biophysical research communications.

[9]  M. Glotzer,et al.  Control of cortical contractility during cytokinesis. , 2008, Biochemical Society transactions.

[10]  Tae-You Kim,et al.  AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity , 2004, Oncogene.

[11]  Yoon Kyung Choi,et al.  AKAP12 Regulates Human Blood–Retinal Barrier Formation by Downregulation of Hypoxia-Inducible Factor-1α , 2007, The Journal of Neuroscience.

[12]  I. Gelman,et al.  v-Src-mediated Down-regulation of SSeCKS Metastasis Suppressor Gene Promoter by the Recruitment of HDAC1 into a USF1-Sp1-Sp3 Complex* , 2007, Journal of Biological Chemistry.

[13]  P. Nelson,et al.  Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: Correlation with culture confluency, cell cycle phase and serum response , 1997, Molecular and Cellular Biochemistry.

[14]  Jeffrey W. Streb,et al.  Cross-species Sequence Analysis Reveals Multiple Charged Residue-rich Domains That Regulate Nuclear/Cytoplasmic Partitioning and Membrane Localization of A Kinase Anchoring Protein 12 (SSeCKS/Gravin)* , 2005, Journal of Biological Chemistry.

[15]  J. Cottom,et al.  A Major, Transformation-sensitive PKC-binding Protein Is Also a PKC Substrate Involved in Cytoskeletal Remodeling* , 1998, The Journal of Biological Chemistry.

[16]  A. Palmieri,et al.  Genetic Profiling of Central Giant Cell Granuloma of the Jaws , 2005, The Journal of craniofacial surgery.

[17]  Takeshi Ono,et al.  Regulation of the Expression of Caspase-9 by the Transcription Factor Activator Protein-4 in Glucocorticoid-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[18]  Hsien-yu Wang,et al.  AKAR2-AKAP12 fusion protein "biosenses" dynamic phosphorylation and localization of a GPCR-based scaffold , 2010, Journal of molecular signaling.

[19]  L. Langeberg,et al.  Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein , 1997, Current Biology.

[20]  R. Eils,et al.  Gene network dynamics controlling keratinocyte migration , 2008, Molecular systems biology.

[21]  I. Gelman The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development . , 2002, Frontiers in bioscience : a journal and virtual library.

[22]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[23]  P. Unger,et al.  The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. , 2001, Cancer research.

[24]  John N Weinstein,et al.  Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. , 2003, Cancer research.

[25]  Q. Luo,et al.  Role of src-suppressed C kinase substrate in rat pulmonary microvascular endothelial hyperpermeability stimulated by inflammatory cytokines , 2010, Inflammation Research.

[26]  Hsien-yu Wang,et al.  Protein kinase A regulates AKAP250 (gravin) scaffold binding to the β2‐adrenergic receptor , 2003, The EMBO journal.

[27]  I. Stamenkovic,et al.  Endothelin Receptor B Inhibition Triggers Apoptosis and Enhances Angiogenesis in Melanomas , 2004, Cancer Research.

[28]  Biaoyang Lin,et al.  The program of androgen-responsive genes in neoplastic prostate epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Cooper,et al.  An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics , 2006, The EMBO journal.

[30]  N. Hayward,et al.  Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma , 2009, Genes, chromosomes & cancer.

[31]  Kimi Yamakoshi,et al.  The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. , 2004, The journal of medical investigation : JMI.

[32]  D. Cafiso,et al.  Interactions controlling the membrane binding of basic protein domains: phenylalanine and the attachment of the myristoylated alanine-rich C-kinase substrate protein to interfaces. , 1999, Biochemistry.

[33]  C. Cordon-Cardo,et al.  Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. , 2003, Cancer research.

[34]  R. Durbin,et al.  Systematic Analysis of Human Protein Complexes Identifies Chromosome Segregation Proteins , 2010, Science.

[35]  S. Kiley,et al.  Identification of a Major Protein Kinase C-binding Protein and Substrate in Rat Embryo Fibroblasts , 1996, The Journal of Biological Chemistry.

[36]  Y. Wang,et al.  Interleukin-17F-induced pulmonary microvascular endothelial monolayer hyperpermeability via the protein kinase C pathway. , 2010, The Journal of surgical research.

[37]  K. Franssila,et al.  Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  S. L. Hyatt,et al.  Correlation between protein kinase C binding proteins and substrates in REF52 cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[39]  N. Shaheen,et al.  Differential gene expression in normal esophagus and Barrett’s esophagus , 2008, Journal of Gastroenterology.

[40]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Gallick,et al.  Src family kinases in tumor progression and metastasis , 2003, Cancer and Metastasis Reviews.

[42]  X. Zhang,et al.  Role of Gadd45α in the density-dependent G1 arrest induced by p27Kip1 , 2003, Oncogene.

[43]  Gene Expression Profile of Leiomyoma and Myometrium and the Effect of Gonadotropin Releasing Hormone Analogue Therapy , 2003, Journal of the Society for Gynecologic Investigation.

[44]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Xi Lin,et al.  Analysis of Pathway Activity in Primary Tumors and NCI60 Cell Lines Using Gene Expression Profiling Data , 2007, Genom. Proteom. Bioinform..

[46]  J. Piontek,et al.  Differential and Regulated Binding of cAMP-dependent Protein Kinase and Protein Kinase C Isoenzymes to Gravin in Human Model Neurons , 2003, Journal of Biological Chemistry.

[47]  Anne-Marie Mes-Masson,et al.  Microarray analysis of gene expression mirrors the biology of an ovarian cancer model , 2001, Oncogene.

[48]  Naveid A Ali,et al.  Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells. , 2010, Molecular bioSystems.

[49]  X. Zhang,et al.  Role of Gadd45alpha in the density-dependent G1 arrest induced by p27(Kip1). , 2003, Oncogene.

[50]  S. Altmeyer-Morel,et al.  Gene expression profiling of alpha‐radiation‐induced rat osteosarcomas: Identification of dysregulated genes involved in radiation‐induced tumorigenesis of bone , 2009, International journal of cancer.

[51]  S. Park,et al.  Role of protein kinase C‐dependent A‐kinase anchoring proteins in lysophosphatidic acid‐induced cAMP signaling in human diploid fibroblasts , 2006, Aging cell.

[52]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Yeul-Hong Kim,et al.  A K A P1 2α is A ssociated with Promoter Methylation in Lung Cancer , 2009 .

[54]  Hyun Seok Song,et al.  SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier , 2003, Nature Medicine.

[55]  J. Kere,et al.  Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma , 2002, British journal of haematology.

[56]  Zhentao Zhang,et al.  1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1 , 2010, BMC Genomics.

[57]  X. Lin,et al.  Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. , 1997, Cancer research.

[58]  N. Cross,et al.  Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia , 2004, British journal of haematology.

[59]  John M Sedivy,et al.  A Large Scale Genetic Analysis of c-Myc-regulated Gene Expression Patterns* 210 , 2003, The Journal of Biological Chemistry.

[60]  S. Altmeyer-Morel,et al.  Silencing of Cited2 and Akap12 genes in radiation-induced rat osteosarcomas. , 2009, Biochemical and biophysical research communications.

[61]  D. Kimelman,et al.  Cell shape regulation by Gravin requires N-terminal membrane effector domains. , 2008, Biochemical and Biophysical Research Communications - BBRC.

[62]  E. Lander,et al.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.

[63]  A. Yen,et al.  Retinoic acid, bromodeoxyuridine, and the Δ205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation , 2004, In Vitro Cellular & Developmental Biology - Animal.

[64]  X. Lin,et al.  Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS. , 1998, Cell motility and the cytoskeleton.

[65]  C. Malbon A-kinase anchoring proteins: trafficking in G-protein-coupled receptors and the proteins that regulate receptor biology. , 2007, Current opinion in drug discovery & development.

[66]  P. Vogt,et al.  Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts , 2001, Oncogene.

[67]  Tetsuo Ito,et al.  A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. , 2006, Gastroenterology.

[68]  Tetsuo Ito,et al.  Hypermethylation of the AKAP12 Promoter is a Biomarker of Barrett's-Associated Esophageal Neoplastic Progression , 2008, Cancer Epidemiology Biomarkers & Prevention.

[69]  C. Van Waes,et al.  Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma , 2007, Genome Biology.

[70]  Xueying Lin,et al.  Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. , 2002, Biochemical and biophysical research communications.

[71]  B. Su,et al.  Growth Factor Inhibition Prostate Cancer Cells Correlates with Vascular Endothelial SSeCKS Metastasis-Suppressing Activity in MatLyLu , 2006 .

[72]  I. Gelman,et al.  SSeCKS/Gravin/AKAP12 Metastasis Suppressor Inhibits Podosome Formation via RhoA- and Cdc42-Dependent Pathways , 2006, Molecular Cancer Research.

[73]  M. Walkiewicz,et al.  Gravin dynamics regulates the subcellular distribution of PKA. , 2009, Experimental cell research.

[74]  I. Gelman,et al.  Functional interaction between the SSeCKS scaffolding protein and the cytoplasmic domain of β1,4-galactosyltransferase , 2001 .

[75]  Brian J. Wilson,et al.  GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis , 2009, Oncogene.

[76]  David C Whiteman,et al.  Reduced expression of IL‐18 is a marker of ultraviolet radiation‐induced melanomas , 2008, International journal of cancer.

[77]  X. Lin,et al.  A Novel src- and ras-suppressed Protein Kinase C Substrate Associated with Cytoskeletal Architecture* , 1996, The Journal of Biological Chemistry.

[78]  I. Gelman,et al.  Functional interaction between the SSeCKS scaffolding protein and the cytoplasmic domain of beta1,4-galactosyltransferase. , 2001, Journal of cell science.

[79]  E. Sim,et al.  Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[80]  M. Rauchman,et al.  Characterization of the gene encoding mouse retinoblastoma binding protein-7, a component of chromatin-remodeling complexes. , 2002, Genomics.

[81]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[82]  I. Gelman,et al.  Role for transcription factor TFII‐I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src , 2011, International journal of cancer.

[83]  John D. Scott,et al.  Dynamic Complexes of β2-Adrenergic Receptors with Protein Kinases and Phosphatases and the Role of Gravin* , 1999, The Journal of Biological Chemistry.

[84]  I. Gelman,et al.  Multiple Promoters Direct Expression of Three AKAP12 Isoforms with Distinct Subcellular and Tissue Distribution Profiles* , 2004, Journal of Biological Chemistry.

[85]  C. Shao,et al.  Biphasic effect of androgens on prostate cancer cells and its correlation with androgen receptor coactivator dopa decarboxylase. , 2007, Journal of andrology.

[86]  S. T. Mees,et al.  SERPINB5 and AKAP12 -- Expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma , 2010, BMC Cancer.

[87]  B. Su,et al.  SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. , 2006, Cancer research.

[88]  T. Curran,et al.  Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1 , 2004, Oncogene.

[89]  P. Nelson,et al.  Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. , 1999, Journal of cell science.

[90]  Hsien-yu Wang,et al.  Src Docks to A-kinase Anchoring Protein Gravin, Regulating β2-Adrenergic Receptor Resensitization and Recycling* , 2007, Journal of Biological Chemistry.

[91]  J. Lindstrom,et al.  Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. , 1992, The Journal of clinical investigation.

[92]  B. Su,et al.  SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C- Raf/MEK/ERK Pathway* , 2009, The Journal of Biological Chemistry.

[93]  I. Gelman,et al.  Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein. , 2002, Experimental cell research.

[94]  Kahraman Tanriverdi,et al.  Gravin gene expression in acute leukaemias: Clinical importance and review of the literature , 2007, Leukemia & lymphoma.

[95]  Eeva Kettunen,et al.  Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. , 2004, Cancer genetics and cytogenetics.

[96]  M. Cazzola,et al.  Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells. , 2009 .

[97]  D. Theodorescu,et al.  Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application , 2006, Clinical Cancer Research.

[98]  Ganesh Venkatraman,et al.  Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. , 2008, Cancer letters.

[99]  Y. Bang,et al.  A-kinase anchoring protein 12 regulates the completion of cytokinesis. , 2008, Biochemical and biophysical research communications.

[100]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[101]  P. Nelson,et al.  Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras , 1995, Molecular and cellular biology.

[102]  Michael Hölzel,et al.  A role for c-Myc in the regulation of ribosomal RNA processing. , 2003, Nucleic acids research.

[103]  A. Moon,et al.  H-Ras-specific Activation of Rac-MKK3/6-p38 Pathway , 2005, Journal of Biological Chemistry.

[104]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[105]  D. Kimelman,et al.  Gravin regulates mesodermal cell behavior changes required for axis elongation during zebrafish gastrulation. , 2007, Genes & development.

[106]  Daniel Nathans,et al.  Specific Ablation of Stat3β Distorts the Pattern of Stat3-Responsive Gene Expression and Impairs Recovery from Endotoxic Shock , 2002, Cell.

[107]  A. Bhattacharyya,et al.  A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. , 2009, Cancer research.

[108]  D. Shih,et al.  FK506, a calcineurin inhibitor, prevents cadmium-induced testicular toxicity in mice. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[109]  S. Baylin,et al.  Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. , 2008, Cancer research.

[110]  B. Foster,et al.  Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia. , 2008, Cancer research.

[111]  S. Knuutila,et al.  Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array , 2002, Oncogene.

[112]  Kimi Yamakoshi,et al.  The p 16 INK 4 aRB pathway : molecular link between cellular senescence and tumor suppression , 2004 .

[113]  P. Taylor,et al.  J Soc Gynecol Investig , 2005 .

[114]  Yoon Kyung Choi,et al.  AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity. , 2007, Cancer letters.

[115]  Hsien-yu Wang,et al.  AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes. , 2004, The Biochemical journal.

[116]  H. Sasaki,et al.  Autoantibody to Gravin is Expressed More Strongly in Younger and Nonthymomatous Patients with Myasthenia Gravis , 2001, Surgery Today.

[117]  D. Cheresh,et al.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis , 2004, The Journal of cell biology.